Sales rise 31.16% to Rs 408.00 crore
Net profit of Astrazeneca Pharma India declined 26.62% to Rs 38.43 crore in the quarter ended September 2024 as against Rs 52.37 crore during the previous quarter ended September 2023. Sales rose 31.16% to Rs 408.00 crore in the quarter ended September 2024 as against Rs 311.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales408.00311.07 31 OPM %12.8816.96 -PBDT60.3560.63 0 PBT51.0356.95 -10 NP38.4352.37 -27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content